GenoTher Summit 2026: accelerating the future of genetic medicine
On 17 and 18 June 2026, the GenoTher biocluster will bring together leading international experts in genetic medicine at the Maison de l’Océan in Paris for the GenoTher Summit 2026.
Dedicated to the future of advanced therapies, the event will gather researchers, clinicians, biotech and pharmaceutical companies, regulators, investors and industrial stakeholders to discuss the scientific, technological and regulatory challenges shaping the next generation of genetic medicines.
The 2026 programme will explore major topics in genetic medicine, including:
• scaling up advanced therapies from N-of-1 approaches to broader patient populations,
• gene editing and in utero gene editing,
• delivery technologies and CNS-targeted delivery strategies,
• scalable gene therapies and biomanufacturing,
• RNA therapeutics,
• artificial intelligence applications in therapeutic development and bioproduction engineering,
• regulatory pathways and patient access to innovative therapies.
The summit will feature keynote lectures, expert panels, roundtables and B2B meetings with internationally recognised specialists in gene and cell therapy.
GenoTher is Europe’s first biocluster fully dedicated to gene therapy and genetic medicine, with the ambition of accelerating the development, industrialisation and accessibility of innovative therapies for patients.
The event is free upon registration.
More information and registration:
GenoTher Summit 2026